Conventional wisdom holds that nonsteroidal anti-inflammatory drugs (NSAIDs) can trigger disease flares in patients with ...
This is the reality for the nearly 3.1 million Americans living with inflammatory bowel disease (IBD), including Crohn’s ...
The oral Janus kinase inhibitor upadacitinib was well tolerated for moderate to severe inflammatory bowel disease over a ...
Early cancer detection may be possible through analysis of gut microbes and stool-based biomarkers linked to multiple ...
Celltrion, Inc. today announced that seven abstracts will be presented at the 2026 Digestive Disease Week® (DDW) Annual Meeting, taking place May 2-5 in Chicago, Illinois. The oral and poster ...
Moderate-to-severe disability affects nearly one-third of patients with inflammatory bowel disease, according to a recent review.
Hosted on MSN
Living well with inflammatory bowel disease
Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, affects millions and can be unpredictable, painful, and exhausting. While there’s no cure yet, advances in ...
A common vitamin may help calm gut inflammation in Crohn’s and colitis, reshaping how doctors approach treatment.
Embedded in the body’s mucosal surfaces, proteins called lectins bind to sugars found on cell surfaces. A team led by MIT ...
NHS bowel cancer screening has now tested nearly 85million people for the disease and uptake has soared with the help of Sun ...
Moderate-to-severe disability affects nearly one-third of patients with inflammatory bowel disease (IBD), according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results